Medical News Today -
21 Mar 2014 11:00
The U.S. Food and Drug Administration has approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis.Leishmaniasis is a disease caused by Leishmania, a parasite which is transmitted to humans through sand fly bites. The disease occurs primarily in people who live in the tropics and subtropics. Most U.S. patients acquire leishmaniasis overseas.
Share this Article